Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-26 @ 4:28 PM
Study NCT ID:
NCT00690560
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2008-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
Sponsor:
Centre Antoine Lacassagne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-03
First Submit QC Date:
None
Study First Post Date:
2008-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-29
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED